{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:11:48Z","timestamp":1787235108444,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bmcl.2021.128308","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T19:00:04Z","timestamp":1628103604000},"page":"128308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Induction of apoptosis, cytotoxicity and radiosensitization by novel 3,4-dihydroquinazolinone derivatives"],"prefix":"10.1016","volume":"49","author":[{"given":"Aiten M.","family":"Soliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M.","family":"Ghorab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bmcl.2021.128308_b0005","first-page":"1","article-title":"Environmental factors inducing human cancers","volume":"41","author":"Parsa","year":"2012","journal-title":"Iran J Public Health"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128308_b0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7603\/s40681-015-0019-4","article-title":"An overview of targeted cancer therapy","volume":"5","author":"Padma","year":"2015","journal-title":"Biomedicine."},{"issue":"21","key":"10.1016\/j.bmcl.2021.128308_b0015","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1158\/0008-5472.CAN-07-6611","article-title":"A history of cancer chemotherapy","volume":"68","author":"DeVita","year":"2008","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.bmcl.2021.128308_b0020","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.7314\/APJCP.2014.15.11.4395","article-title":"Endpoint of cancer treatment: targeted therapies","volume":"15","author":"Topcul","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128308_b0025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4161\/auto.23691","article-title":"DAMPs and autophagy: cellular adaptation to injury and unscheduled cell death","volume":"9","author":"Zhang","year":"2013","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128308_b0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128308_b0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/imr.12541","article-title":"Caspase-8: regulating life and death","volume":"277","author":"Tummers","year":"2017","journal-title":"Immunol Rev"},{"issue":"6824","key":"10.1016\/j.bmcl.2021.128308_b0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/35065125","article-title":"A conserved XIAP-interaction motif in caspase-9 and Smac\/DIABLO regulates caspase activity and apoptosis","volume":"410","author":"Srinivasula","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128308_b0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1101\/gad.13.3.239","article-title":"IAP family proteins\u2014suppressors of apoptosis","volume":"13","author":"Deveraux","year":"1999","journal-title":"Genes Dev"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128308_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-019-0484-5","article-title":"Apoptosis of cancer cells is triggered by selective crosslinking and inhibition of receptor tyrosine kinases","volume":"2","author":"Wang","year":"2019","journal-title":"Commun Biol"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128308_b0055","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128308_b0060","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2007.02.006","article-title":"Cellular responses to EGFR inhibitors and their relevance to cancer therapy","volume":"254","author":"Dutta","year":"2007","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128308_b0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/14756366.2020.1854243","article-title":"Synthesis of some quinazolinones inspired from the natural alkaloid L-norephedrine as EGFR inhibitors and radiosensitizers","volume":"36","author":"Ghorab","year":"2021","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128308_b0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-5793(98)00224-5","article-title":"Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts","volume":"425","author":"Verbeek","year":"1998","journal-title":"FEBS Lett"},{"issue":"8","key":"10.1016\/j.bmcl.2021.128308_b0075","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0006-2952(00)00425-1","article-title":"Role of conformational alteration in the epidermal growth factor receptor (EGFR) function","volume":"60","author":"Bishayee","year":"2000","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.bmcl.2021.128308_b0080","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1248\/bpb.25.1432","article-title":"Synthesis, analgesic, anti-inflammatory and antibacterial activities of some novel 2-phenyl-3-substituted quinazolin-4 (3H) ones","volume":"25","author":"Alagarsamy","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bmcl.2021.128308_b0085","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.2147\/IJN.S241433","article-title":"Novel N-(Substituted) Thioacetamide Quinazolinone Benzenesulfonamides as Antimicrobial Agents","volume":"15","author":"Ghorab","year":"2020","journal-title":"Int J Nanomedicine."},{"issue":"5","key":"10.1016\/j.bmcl.2021.128308_b0090","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/14756366.2013.845820","article-title":"Synthesis and characterization of quinazoline derivatives: search for hybrid molecule as diuretic and antihypertensive agents","volume":"29","author":"Rahman","year":"2014","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmcl.2021.128308_b0095","article-title":"Radiomodulatory effect of a non-electrophilic NQO1 inducer identified in a screen of new 6, 8-diiodoquinolin-4 (3H)-ones carrying a sulfonamide moiety","volume":"112467","author":"Soliman","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128308_b0100","doi-asserted-by":"crossref","first-page":"112333","DOI":"10.1016\/j.ejmech.2020.112333","article-title":"Antioxidant activity of novel quinazolinones bearing sulfonamide: Potential radiomodulatory effects on liver tissues via NF-\u03baB\/PON1 pathway","volume":"197","author":"Soliman","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128308_b0105","doi-asserted-by":"crossref","first-page":"104618","DOI":"10.1016\/j.bioorg.2020.104618","article-title":"Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX\/XII inhibitors","volume":"107","author":"Ghorab","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2021.128308_b0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejmech.2017.09.061","article-title":"Discovery of Benzo [g] quinazolin benzenesulfonamide derivatives as dual EGFR\/HER2 inhibitors","volume":"141","author":"Alsaid","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128308_b0115","doi-asserted-by":"crossref","first-page":"102956","DOI":"10.1016\/j.bioorg.2019.102956","article-title":"Exploration of N-alkyl-2-[(4-oxo-3-(4-sulfamoylphenyl)-3, 4-dihydroquinazolin-2-yl) thio] acetamide derivatives as anticancer and radiosensitizing agents","volume":"88","author":"Soliman","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2021.128308_b0120","doi-asserted-by":"crossref","first-page":"112640","DOI":"10.1016\/j.ejmech.2020.112640","article-title":"Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015\u20132019)","volume":"204","author":"Bhatia","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128308_b0125","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1039\/C7MD00097A","article-title":"An insight into the therapeutic potential of quinazoline derivatives as anticancer agents","volume":"8","author":"Shagufta","year":"2017","journal-title":"MedChemComm."},{"key":"10.1016\/j.bmcl.2021.128308_b0130","series-title":"The Carbonic Anhydrases","first-page":"13","author":"Chegwidden","year":"2000"},{"key":"10.1016\/j.bmcl.2021.128308_b0135","doi-asserted-by":"crossref","first-page":"112449","DOI":"10.1016\/j.ejmech.2020.112449","article-title":"Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity","volume":"200","author":"Soliman","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128308_b0140","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ejmech.2016.10.020","article-title":"Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers","volume":"124","author":"Ghorab","year":"2016","journal-title":"Eur J Med Chem"},{"issue":"25","key":"10.1016\/j.bmcl.2021.128308_b0145","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1021\/jm030268b","article-title":"Synthesis and structure\u2212 activity relationship of novel, highly potent metharyl and methcycloalkyl cyclooxygenase-2 (COX-2) selective inhibitors","volume":"46","author":"Khanapure","year":"2003","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bmcl.2021.128308_b0150","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1016\/j.ejmech.2010.04.034","article-title":"New substituted 4-arylaminoquinazolines as potent inhibitors of breast tumor cell lines: in vitro and docking experiments","volume":"45","author":"de Oliveira","year":"2010","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128308_b0155","doi-asserted-by":"crossref","first-page":"1900304","DOI":"10.1002\/ardp.201900304","article-title":"Synthesis, characterization, biological evaluation, and molecular docking studies of some piperonyl-based 4-thiazolidinone derivatives","volume":"353","author":"Genc Bilgicli","year":"2020","journal-title":"Arch Pharm"},{"issue":"13","key":"10.1016\/j.bmcl.2021.128308_b0160","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.bmc.2019.05.020","article-title":"Capsaicin-like analogue induced selective apoptosis in A2058 melanoma cells: Design, synthesis and molecular modeling","volume":"27","author":"Pereira","year":"2019","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128308_b0165","doi-asserted-by":"crossref","DOI":"10.1038\/srep11544","article-title":"Synthesis, characterization and apoptotic activity of quinazolinone Schiff base derivatives toward MCF-7 cells via intrinsic and extrinsic apoptosis pathways","volume":"5","author":"Zahedifard","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2021.128308_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fct.2015.11.016","article-title":"A novel quinazolinone chalcone derivative induces mitochondrial dependent apoptosis and inhibits PI3K\/Akt\/mTOR signaling pathway in human colon cancer HCT-116 cells","volume":"87","author":"Wani","year":"2016","journal-title":"Food Chem Toxicol"},{"issue":"10","key":"10.1016\/j.bmcl.2021.128308_b0175","first-page":"1191","article-title":"Design, synthesis and biological evaluation of some novel quinazolinone derivatives as potent apoptotic inducers. Future","volume":"10","author":"Nowar","year":"2018","journal-title":"Med Chem"},{"issue":"10","key":"10.1016\/j.bmcl.2021.128308_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-0960-8","article-title":"Idelalisib promotes Bim-dependent apoptosis through AKT\/FoxO3a in hepatocellular carcinoma","volume":"9","author":"Yue","year":"2018","journal-title":"Cell Death Dis"},{"issue":"12","key":"10.1016\/j.bmcl.2021.128308_b0185","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/md17120658","article-title":"A natural quinazoline derivative from marine sponge hyrtios erectus induces apoptosis of breast cancer cells via ROS production and intrinsic or extrinsic apoptosis pathways","volume":"17","author":"De","year":"2019","journal-title":"Mar Drugs"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128308_b0190","doi-asserted-by":"crossref","first-page":"259","DOI":"10.21873\/anticanres.14772","article-title":"Antitumor Effects of the Novel Quinazolinone Holu-12: Induction of Mitotic Arrest and Apoptosis in Human Oral Squamous Cell Carcinoma CAL27 Cells","volume":"41","author":"Lai","year":"2021","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bmcl.2021.128308_b0195","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ejmech.2015.03.053","article-title":"Distinct novel quinazolinone exhibits selective inhibition in MGC-803 cancer cells by dictating mutant p53 function","volume":"95","author":"Zhang","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128308_b0200","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ejmech.2016.08.060","article-title":"Biological evaluation of some new N-(2, 6-dimethoxypyrimidinyl) thioureido benzenesulfonamide derivatives as potential antimicrobial and anticancer agents","volume":"124","author":"Ghorab","year":"2016","journal-title":"Eur J Med Chem"},{"issue":"27","key":"10.1016\/j.bmcl.2021.128308_b0205","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/S0040-4039(03)01188-2","article-title":"A convenient \u2018catch and release\u2019synthesis of fused 2-alkylthio-pyrimidinones mediated by polymer-bound BEMP","volume":"44","author":"Adams","year":"2003","journal-title":"Tetrahedron Lett"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128308_b0210","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/cells2010163","article-title":"Regulation of Apoptosis by Inhibitors of Apoptosis (IAPs)","volume":"2","author":"Berthelet","year":"2013","journal-title":"Cells."},{"issue":"4","key":"10.1016\/j.bmcl.2021.128308_b0215","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4103\/0971-5916.159250","article-title":"Survivin: A molecular biomarker in cancer","volume":"141","author":"Jaiswal","year":"2015","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.bmcl.2021.128308_b0220","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2017.6999","article-title":"Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas","author":"Dizdar","year":"2017","journal-title":"Oncol Lett."},{"issue":"6","key":"10.1016\/j.bmcl.2021.128308_b0225","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in cancer: intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"10.1016\/j.bmcl.2021.128308_b0230","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/1947601911432495","article-title":"Activation of p21-Dependent G1\/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress","volume":"2","author":"Hoeferlin","year":"2011","journal-title":"Genes Cancer"},{"issue":"8","key":"10.1016\/j.bmcl.2021.128308_b0235","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/jmg.2009.066944","article-title":"Apoptosis and cancer: mutations within caspase genes","volume":"46","author":"Ghavami","year":"2009","journal-title":"J Med Genet"},{"issue":"6","key":"10.1016\/j.bmcl.2021.128308_b0240","doi-asserted-by":"crossref","first-page":"a008672","DOI":"10.1101\/cshperspect.a008672","article-title":"Cellular mechanisms controlling caspase activation and function","volume":"5","author":"Parrish","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"10.1016\/j.bmcl.2021.128308_b0245","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1128\/MCB.22.6.1754-1766.2002","article-title":"IAP suppression of apoptosis involves distinct mechanisms: the TAK1\/JNK1 signaling cascade and caspase inhibition","volume":"22","author":"Sanna","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128308_b0250","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1091\/mbc.6.4.387","article-title":"Inhibition of cyclin-dependent kinases by p21","volume":"6","author":"Harper","year":"1995","journal-title":"Mol Biol Cell"},{"issue":"10","key":"10.1016\/j.bmcl.2021.128308_b0255","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/09553002.2016.1206235","article-title":"Low-dose hyper-radiosensitivity in human hepatocellular HepG2 cells is associated with Cdc25C-mediated G2\/M cell cycle checkpoint control","volume":"92","author":"Xue","year":"2016","journal-title":"Int J Rad Biol."},{"issue":"6313","key":"10.1016\/j.bmcl.2021.128308_b0260","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1126\/science.aaf7532","article-title":"The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury","volume":"354","author":"Hu","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2021.128308_b0265","doi-asserted-by":"crossref","first-page":"109326","DOI":"10.1016\/j.radphyschem.2020.109326","article-title":"Radiosensitization potential of caffeic acid phenethyl ester and the long non-coding RNAs in response to 60Co\u03b3 radiation in mouse hepatoma cells","volume":"181","author":"Zhang","year":"2021","journal-title":"Radiat Phys Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128308_b0270","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1269\/jrr.42.21","article-title":"Radioprotectors in radiotherapy","volume":"42","author":"Nair","year":"2001","journal-title":"J Rad Res"},{"issue":"173","key":"10.1016\/j.bmcl.2021.128308_b0275","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1126\/scitranslmed.3005148","article-title":"New paradigms and future challenges in radiation oncology: an update of biological targets and technology","volume":"5","author":"Liauw","year":"2013","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.bmcl.2021.128308_b0280","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1349-7006.2009.01190.x","article-title":"Radiosensitizing effects of gefitinib at different administration times in vitro","volume":"100","author":"Zhuang","year":"2009","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128308_b0285","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ijrobp.2003.09.094","article-title":"Rationale and clinical basis for combining gefitinib (IRESSA, ZD1839) with radiation therapy for solid tumors","volume":"58","author":"Ochs","year":"2004","journal-title":"Int J Rad Oncol Biol Phys"},{"issue":"48","key":"10.1016\/j.bmcl.2021.128308_b0290","doi-asserted-by":"crossref","first-page":"46265","DOI":"10.1074\/jbc.M207135200","article-title":"Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor","volume":"277","author":"Stamos","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2021.128308_b0295","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.bioorg.2018.07.015","article-title":"Dual EGFR\/HER2 inhibitors and apoptosis inducers: New benzo [g] quinazoline derivatives bearing benzenesulfonamide as anticancer and radiosensitizers","volume":"80","author":"Ghorab","year":"2018","journal-title":"Bioorg Chem"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128308_b0300","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8","article-title":"Evaluation of the FLEXX incremental construction algorithm for protein\u2013ligand docking","volume":"37","author":"Kramer","year":"1999","journal-title":"Proteins"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21005357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21005357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:42:50Z","timestamp":1760773370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21005357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":60,"alternative-id":["S0960894X21005357"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128308","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of apoptosis, cytotoxicity and radiosensitization by novel 3,4-dihydroquinazolinone derivatives","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128308"}}